Product Code: ETC13312613 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Drug Eluting Stent Market was valued at USD 6.2 Billion in 2024 and is expected to reach USD 10.1 Billion by 2031, growing at a compound annual growth rate of 18.39% during the forecast period (2025-2031).
The Global Drug Eluting Stent Market is experiencing steady growth due to the rising prevalence of cardiovascular diseases, technological advancements in stent design, and increasing adoption of minimally invasive procedures. Drug eluting stents are widely used in the treatment of coronary artery disease as they help prevent restenosis and improve patient outcomes. Key players in the market are focusing on developing innovative stents with improved drug delivery systems and biocompatible materials to enhance efficacy and reduce complications. North America and Europe dominate the market due to well-established healthcare infrastructure and high prevalence of heart diseases. However, the Asia-Pacific region is emerging as a lucrative market with a growing elderly population and increasing healthcare expenditure. Overall, the Global Drug Eluting Stent Market is projected to continue growing as the demand for minimally invasive cardiovascular interventions rises worldwide.
The Global Drug Eluting Stent Market is experiencing significant growth due to the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. Technological advancements such as biodegradable stents and drug-coated balloons are driving innovation in the market. Additionally, the growing elderly population and changing lifestyle habits are contributing to the demand for drug eluting stents. Emerging markets in Asia-Pacific and Latin America present lucrative opportunities for market expansion, while strategic partnerships and collaborations among key players are enhancing product development and market penetration. However, stringent regulatory requirements and the high cost associated with drug eluting stents pose challenges to market growth. Overall, the market is expected to continue expanding as manufacturers focus on developing more advanced and cost-effective solutions to meet the growing demand for cardiovascular interventions.
The Global Drug Eluting Stent Market faces several challenges, including intense competition among key players leading to pricing pressures, stringent regulatory requirements for product approval and market entry, potential complications associated with stent implantation such as restenosis and thrombosis, and the emergence of alternative treatment options like drug-coated balloons and bioresorbable stents. Additionally, the market is susceptible to economic fluctuations and healthcare budget constraints in various regions, which can impact the adoption and sales of drug eluting stents. Continuous research and development efforts to improve stent design and efficacy, addressing safety concerns, and expanding market access in developing economies are crucial strategies for companies operating in this market to overcome these challenges and sustain growth.
The Global Drug-Eluting Stent market is primarily driven by the increasing prevalence of cardiovascular diseases, coupled with the rising geriatric population worldwide. Technological advancements in stent design, such as biodegradable polymers and drug coatings, are also contributing to market growth by improving patient outcomes and reducing the need for repeat procedures. Additionally, the growing adoption of minimally invasive procedures and the expanding healthcare infrastructure in developing economies are fueling the demand for drug-eluting stents. Moreover, the rising awareness about the benefits of these stents in preventing restenosis and reducing the risk of complications post-surgery is further propelling market expansion. Overall, these factors are driving the growth of the Global Drug-Eluting Stent market and are expected to continue shaping its trajectory in the coming years.
Government policies related to the Global Drug Eluting Stent Market primarily focus on regulatory approval processes, quality standards, and reimbursement policies. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in Europe play a crucial role in evaluating the safety and efficacy of drug-eluting stents before they can be marketed. These agencies have established stringent guidelines to ensure the quality and performance of these medical devices. Additionally, reimbursement policies set by government healthcare systems impact the adoption and utilization of drug-eluting stents, with some countries providing financial incentives for the use of innovative technologies. Overall, government policies aim to safeguard patient health, promote innovation in healthcare technologies, and ensure equitable access to advanced medical treatments in the Global Drug Eluting Stent Market.
The Global Drug-Eluting Stent Market is expected to witness steady growth in the coming years due to the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. Technological advancements in stent design and materials, along with the growing elderly population, are also contributing to market expansion. The market is likely to be driven by the demand for innovative stents with improved efficacy and safety profiles, as well as the rising healthcare expenditure in emerging economies. However, price competition among key market players and stringent regulatory requirements may pose challenges to market growth. Overall, the Global Drug-Eluting Stent Market is anticipated to show positive growth trends, driven by a combination of technological advancements, increasing patient awareness, and expanding healthcare infrastructure worldwide.
In the Global Drug Eluting Stent Market, Asia is projected to witness significant growth due to the increasing prevalence of cardiovascular diseases and the rising adoption of advanced medical technologies in countries like China and India. North America is expected to dominate the market due to the high healthcare expenditure, well-established healthcare infrastructure, and favorable reimbursement policies. Europe is also a key market player, driven by the presence of major stent manufacturers and the growing geriatric population. The Middle East and Africa region is anticipated to experience steady growth attributed to improving healthcare facilities and rising awareness about cardiovascular diseases. Latin America is poised for growth due to the increasing focus on healthcare infrastructure development and the rising prevalence of lifestyle-related diseases in countries like Brazil and Mexico.
Global Drug Eluting Stent Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Drug Eluting Stent Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Drug Eluting Stent Market Revenues & Volume, 2021 & 2031F |
3.3 Global Drug Eluting Stent Market - Industry Life Cycle |
3.4 Global Drug Eluting Stent Market - Porter's Five Forces |
3.5 Global Drug Eluting Stent Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Drug Eluting Stent Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Global Drug Eluting Stent Market Revenues & Volume Share, By Material Type, 2021 & 2031F |
3.8 Global Drug Eluting Stent Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Global Drug Eluting Stent Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Drug Eluting Stent Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Drug Eluting Stent Market Trends |
6 Global Drug Eluting Stent Market, 2021 - 2031 |
6.1 Global Drug Eluting Stent Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Drug Eluting Stent Market, Revenues & Volume, By Paclitaxel-Eluting Stents, 2021 - 2031 |
6.1.3 Global Drug Eluting Stent Market, Revenues & Volume, By Sirolimus-Eluting Stents, 2021 - 2031 |
6.1.4 Global Drug Eluting Stent Market, Revenues & Volume, By Everolimus-Eluting Stents, 2021 - 2031 |
6.1.5 Global Drug Eluting Stent Market, Revenues & Volume, By Zotarolimus-Eluting Stents, 2021 - 2031 |
6.2 Global Drug Eluting Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Drug Eluting Stent Market, Revenues & Volume, By Polymer-Based Stents, 2021 - 2031 |
6.2.3 Global Drug Eluting Stent Market, Revenues & Volume, By Biodegradable Stents, 2021 - 2031 |
6.2.4 Global Drug Eluting Stent Market, Revenues & Volume, By Metallic Stents, 2021 - 2031 |
6.2.5 Global Drug Eluting Stent Market, Revenues & Volume, By Composite Stents, 2021 - 2031 |
6.3 Global Drug Eluting Stent Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Drug Eluting Stent Market, Revenues & Volume, By Coronary Artery Disease (CAD), 2021 - 2031 |
6.3.3 Global Drug Eluting Stent Market, Revenues & Volume, By Peripheral Artery Disease (PAD), 2021 - 2031 |
6.3.4 Global Drug Eluting Stent Market, Revenues & Volume, By Renal Artery Stenosis, 2021 - 2031 |
6.3.5 Global Drug Eluting Stent Market, Revenues & Volume, By Carotid Artery Disease, 2021 - 2031 |
6.4 Global Drug Eluting Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Drug Eluting Stent Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Drug Eluting Stent Market, Revenues & Volume, By Cardiology Clinics, 2021 - 2031 |
6.4.4 Global Drug Eluting Stent Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.4.5 Global Drug Eluting Stent Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
7 North America Drug Eluting Stent Market, Overview & Analysis |
7.1 North America Drug Eluting Stent Market Revenues & Volume, 2021 - 2031 |
7.2 North America Drug Eluting Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Drug Eluting Stent Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4 North America Drug Eluting Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
7.5 North America Drug Eluting Stent Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America Drug Eluting Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Drug Eluting Stent Market, Overview & Analysis |
8.1 Latin America (LATAM) Drug Eluting Stent Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Drug Eluting Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Drug Eluting Stent Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
8.4 Latin America (LATAM) Drug Eluting Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
8.5 Latin America (LATAM) Drug Eluting Stent Market, Revenues & Volume, By Application, 2021 - 2031 |
8.6 Latin America (LATAM) Drug Eluting Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Drug Eluting Stent Market, Overview & Analysis |
9.1 Asia Drug Eluting Stent Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Drug Eluting Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Drug Eluting Stent Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
9.4 Asia Drug Eluting Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
9.5 Asia Drug Eluting Stent Market, Revenues & Volume, By Application, 2021 - 2031 |
9.6 Asia Drug Eluting Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Drug Eluting Stent Market, Overview & Analysis |
10.1 Africa Drug Eluting Stent Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Drug Eluting Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Drug Eluting Stent Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
10.4 Africa Drug Eluting Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
10.5 Africa Drug Eluting Stent Market, Revenues & Volume, By Application, 2021 - 2031 |
10.6 Africa Drug Eluting Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Drug Eluting Stent Market, Overview & Analysis |
11.1 Europe Drug Eluting Stent Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Drug Eluting Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Drug Eluting Stent Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
11.4 Europe Drug Eluting Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
11.5 Europe Drug Eluting Stent Market, Revenues & Volume, By Application, 2021 - 2031 |
11.6 Europe Drug Eluting Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Drug Eluting Stent Market, Overview & Analysis |
12.1 Middle East Drug Eluting Stent Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Drug Eluting Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Drug Eluting Stent Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Drug Eluting Stent Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
12.4 Middle East Drug Eluting Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
12.5 Middle East Drug Eluting Stent Market, Revenues & Volume, By Application, 2021 - 2031 |
12.6 Middle East Drug Eluting Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Drug Eluting Stent Market Key Performance Indicators |
14 Global Drug Eluting Stent Market - Export/Import By Countries Assessment |
15 Global Drug Eluting Stent Market - Opportunity Assessment |
15.1 Global Drug Eluting Stent Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Drug Eluting Stent Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
15.3 Global Drug Eluting Stent Market Opportunity Assessment, By Material Type, 2021 & 2031F |
15.4 Global Drug Eluting Stent Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Global Drug Eluting Stent Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Drug Eluting Stent Market - Competitive Landscape |
16.1 Global Drug Eluting Stent Market Revenue Share, By Companies, 2024 |
16.2 Global Drug Eluting Stent Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |